Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality
- PMID: 21418635
- PMCID: PMC3219371
- DOI: 10.1186/cc10114
Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality
Abstract
Introduction: To estimate the incidence of intensive care unit (ICU)-acquired bloodstream infection (BSI) and its independent effect on hospital mortality.
Methods: We retrospectively studied acquisition of BSI during admissions of >72 hours to adult ICUs from two university-affiliated hospitals. We obtained demographics, illness severity and co-morbidity data from ICU databases and microbiological diagnoses from departmental electronic records. We assessed survival at hospital discharge or at 90 days if still hospitalized.
Results: We identified 6339 ICU admissions, 330 of which were complicated by BSI (5.2%). Median time to first positive culture was 7 days (IQR 5-12). Overall mortality was 23.5%, 41.2% in patients with BSI and 22.5% in those without. Patients who developed BSI had higher illness severity at ICU admission (median APACHE III score: 79 vs. 68, P < 0.001). After controlling for illness severity and baseline demographics by Cox proportional-hazard model, BSI remained independently associated with risk of death (hazard ratio from diagnosis 2.89; 95% confidence interval 2.41-3.46; P < 0.001). However, only 5% of the deaths in this model could be attributed to acquired-BSI, equivalent to an absolute decrease in survival of 1% of the total population. When analyzed by microbiological classification, Candida, Staphylococcus aureus and gram-negative bacilli infections were independently associated with increased risk of death. In a sub-group analysis intravascular catheter associated BSI remained associated with significant risk of death (hazard ratio 2.64; 95% confidence interval 1.44-4.83; P = 0.002).
Conclusions: ICU-acquired BSI is associated with greater in-hospital mortality, but complicates only 5% of ICU admissions and its absolute effect on population mortality is limited. These findings have implications for the design and interpretation of clinical trials.
Figures





Comment in
-
Impact estimates of nosocomial bloodstream infection: looking from a different angle.Crit Care. 2011;15(3):169. doi: 10.1186/cc10271. Epub 2011 Jun 30. Crit Care. 2011. PMID: 21745423 Free PMC article.
Similar articles
-
Intensive-care-unit-acquired bloodstream infections in a regional critically ill population.J Hosp Infect. 2004 Oct;58(2):137-45. doi: 10.1016/j.jhin.2004.06.007. J Hosp Infect. 2004. PMID: 15474185
-
Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.JAMA. 2016 Apr 12;315(14):1469-79. doi: 10.1001/jama.2016.2691. JAMA. 2016. PMID: 26975785
-
Intensive care unit-acquired blood stream infections: a 5-year retrospective analysis of a single tertiary care hospital in Korea.Infection. 2014 Oct;42(5):875-81. doi: 10.1007/s15010-014-0651-z. Epub 2014 Jul 17. Infection. 2014. PMID: 25030309
-
Epidemiology and Prognosis of Intensive Care Unit-Acquired Bloodstream Infection.Am J Trop Med Hyg. 2020 Jul;103(1):508-514. doi: 10.4269/ajtmh.19-0877. Epub 2020 Apr 16. Am J Trop Med Hyg. 2020. PMID: 32314689 Free PMC article.
-
Risk factors for bloodstream infection in COVID-19 patients in intensive care units: a systematic review and meta-analysis.BMC Infect Dis. 2025 Jan 3;25(1):13. doi: 10.1186/s12879-024-10420-1. BMC Infect Dis. 2025. PMID: 39754037 Free PMC article.
Cited by
-
ICU-acquired infections in immunocompromised patients.Intensive Care Med. 2024 Mar;50(3):332-349. doi: 10.1007/s00134-023-07295-2. Epub 2024 Jan 10. Intensive Care Med. 2024. PMID: 38197931 Review.
-
Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.Antimicrob Resist Infect Control. 2020 Aug 14;9(1):132. doi: 10.1186/s13756-020-00791-w. Antimicrob Resist Infect Control. 2020. PMID: 32795380 Free PMC article.
-
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?Infection. 2021 Dec;49(6):1107-1131. doi: 10.1007/s15010-021-01640-7. Epub 2021 Jun 16. Infection. 2021. PMID: 34132989 Review.
-
Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):357-65. doi: 10.1007/s10096-014-2239-z. Epub 2014 Sep 13. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25217227
-
Corticosteroid outcome may be dependent of duration of use in severe COVID-19.Korean J Intern Med. 2023 May;38(3):382-392. doi: 10.3904/kjim.2022.201. Epub 2023 Apr 11. Korean J Intern Med. 2023. PMID: 37038264 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources